Quantum software developer Zapata Quantum (OTCQB: ZPTA) has formally joined the IBM Quantum Network, expanding its hardware access and application co-development pipeline across IBM’s superconducting quantum processing units (QPUs). The collaboration aims to bridge the “quantum application gap”—the disparity between rapidly advancing QPU hardware capabilities and enterprise readiness to identify, benchmark, and deploy mission-critical quantum software workflows.
Under the agreement, Zapata will integrate insights from IBM’s fault-tolerant and utility-scale superconducting processors into Quantum Pilot™, Zapata’s hardware-agnostic platform for quantum application discovery and development. The joining of the network builds upon prior joint research between IBM and Zapata scientists, including a landmark hybrid quantum-classical generative model study published in Nature Biotechnology (selected as one of the journal’s top 10 papers of 2025) that identified novel small-molecule inhibitors targeting the KRAS cancer mutation using a 16-qubit IBM processor, as well as foundational research on variational quantum factoring published in npj Quantum Information.
| [ Zapata Quantum / IBM Quantum Network Partnership Highlights ] | ||
|---|---|---|
| Technical Focus Area | Operational & Software Framework | Enterprise Target Applications |
| • QPU Access Layer | • Direct access to IBM Quantum hardware fleet • Superconducting QPU execution optimization | • High-speed circuit execution for industrial chemistry, optimization, and defense |
| • Software Platform | • Zapata Quantum Pilot™ platform integration • Quantum Application Intelligence™ engine | • Systematic identification, resource estimation, and compilation of logical circuits |
| • Joint Research Validation | • Nature Biotechnology (2025 Top 10 paper) • npj Quantum Information (variational factoring) | • Generative quantum-classical drug discovery targeting KRAS cancer mutations |
By pairing IBM’s high-speed superconducting QPU roadmap with Zapata’s application engineering tools, the partnership seeks to establish practical resource requirements and logical circuit compilation pathways for industrial clients across pharmaceuticals, materials science, defense, and financial modeling ahead of fault-tolerant QPU availability.
Review the full corporate release on the Zapata Quantum Investor Relations Portal here, inspect the peer-reviewed KRAS cancer research manuscript in Nature Biotechnology here, examine variational quantum factoring results in npj Quantum Information here, and read our previous coverage on Zapata’s Quantum Pilot platform launch here.
In GQI Portal
The players behind the news
The team that writes QCR tracks every company, deal and technology in the GQI Factory, GQI's verified database of the quantum industry. Next up: every story linked to its players, coming to QCR's paid plans.
- Players Companies and institutions across the quantum industry, by segment.
- Scorecards How the players compare on hardware, software, funding and more.
Newsletter
QCR Alerts in your inbox
The latest reporting and analysis from Quantum Computing Report. Free, unsubscribe any time.